With the Sleep Apnoea Trial results due in Q4.
I thought it might be a good time to post an article from December, 2020 on this therapy IHL-42X
In a statement to the market, Incannex said...
if the Alfred trial leads to a “positive result”, the trial will serve as a “major valuation inflection point” for the company.
Click to View Article
Good luck all, time has gone so quickly !